nderstanding growth in patients with epidermolysis bullosa.
- Conditions
- Q81.8Epidermolysis bullosa dystrophicaOther epidermolysis bullosaQ81.2
- Registration Number
- DRKS00013002
- Lead Sponsor
- Epidermolysis bullosa-Zentrum Freiburg, Klinik für Dermatologie und Venerologie, Universitätsklinikum Freiburg - Eigenforschungsprojekt
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 871
Inclusion Criteria
Molecular diagnosis of epidermolysis bullosa
- At least one clinical presentation to the Epidermolysis bullosa center Freiburg
Data on height and weight measurements are gathered from patient files of the years 2002 to now for retrospective analysis. Prospective data collection takes place as of ethic consent in 04/2017 and will continue until the summer of 2018.
Exclusion Criteria
- No molecular diagnosis of epidermolysis bullosa
- No clinical presentation to the Epidermolysis bullosa center Freiburg
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Retrospective analysis of data from patient files:<br>-Weight in kg as measured on clinical presentation to the Epidermolysis bullosa center Freiburg with calibrated scales<br>-Height in cm as measured on clinical presentation to the Epidermolysis bullosa center Freiburg with calibrated measure<br>The primary outcome is the existence of failure to thrive (i.e. weight and height below 3. percentile of WHO-growth curves).
- Secondary Outcome Measures
Name Time Method Retrospective analysis of data from patient files:<br>-Weight in kg as measured on clinical presentation to the Epidermolysis bullosa center Freiburg with calibrated scales<br>-Height in cm as measured on clinical presentation to the Epidermolysis bullosa center Freiburg with calibrated measure<br><br>Secondary outcomes are the existence of <br>-Underweight (i.e. weight below 3. percentile of WHO-growth curves)<br>-Short stature (i.e. height below 3. percentile of WHO-growth curves)